Cargando…

Biocompatibility of single-walled carbon nanotube composites for bone regeneration

OBJECTIVES: The purpose of this study was to evaluate in vivo biocompatibility of novel single-walled carbon nanotubes (SWCNT)/poly(lactic-co-glycolic acid) (PLAGA) composites for applications in bone and tissue regeneration. METHODS: A total of 60 Sprague-Dawley rats (125 g to 149 g) were implanted...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, A., Liberati, T. A., Verhulst, S. J., Main, B. J., Roberts, M. H., Potty, A. G. R., Pylawka, T. K., El-Amin III, S. F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: British Editorial Society of Bone and Joint Surgery 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438669/
https://www.ncbi.nlm.nih.gov/pubmed/25943595
http://dx.doi.org/10.1302/2046-3758.45.2000382
_version_ 1782372379703377920
author Gupta, A.
Liberati, T. A.
Verhulst, S. J.
Main, B. J.
Roberts, M. H.
Potty, A. G. R.
Pylawka, T. K.
El-Amin III, S. F.
author_facet Gupta, A.
Liberati, T. A.
Verhulst, S. J.
Main, B. J.
Roberts, M. H.
Potty, A. G. R.
Pylawka, T. K.
El-Amin III, S. F.
author_sort Gupta, A.
collection PubMed
description OBJECTIVES: The purpose of this study was to evaluate in vivo biocompatibility of novel single-walled carbon nanotubes (SWCNT)/poly(lactic-co-glycolic acid) (PLAGA) composites for applications in bone and tissue regeneration. METHODS: A total of 60 Sprague-Dawley rats (125 g to 149 g) were implanted subcutaneously with SWCNT/PLAGA composites (10 mg SWCNT and 1gm PLAGA 12 mm diameter two-dimensional disks), and at two, four, eight and 12 weeks post-implantation were compared with control (Sham) and PLAGA (five rats per group/point in time). Rats were observed for signs of morbidity, overt toxicity, weight gain and food consumption, while haematology, urinalysis and histopathology were completed when the animals were killed. RESULTS: No mortality and clinical signs were observed. All groups showed consistent weight gain, and the rate of gain for each group was similar. All groups exhibited a similar pattern for food consumption. No difference in urinalysis, haematology, and absolute and relative organ weight was observed. A mild to moderate increase in the summary toxicity (sumtox) score was observed for PLAGA and SWCNT/PLAGA implanted animals, whereas the control animals did not show any response. Both PLAGA and SWCNT/PLAGA showed a significantly higher sumtox score compared with the control group at all time intervals. However, there was no significant difference between PLAGA and SWCNT/PLAGA groups. CONCLUSIONS: Our results demonstrate that SWCNT/PLAGA composites exhibited in vivo biocompatibility similar to the Food and Drug Administration approved biocompatible polymer, PLAGA, over a period of 12 weeks. These results showed potential of SWCNT/PLAGA composites for bone regeneration as the low percentage of SWCNT did not elicit a localised or general overt toxicity. Following the 12-week exposure, the material was considered to have an acceptable biocompatibility to warrant further long-term and more invasive in vivo studies. Cite this article: Bone Joint Res 2015;4:70–7
format Online
Article
Text
id pubmed-4438669
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher British Editorial Society of Bone and Joint Surgery
record_format MEDLINE/PubMed
spelling pubmed-44386692015-05-26 Biocompatibility of single-walled carbon nanotube composites for bone regeneration Gupta, A. Liberati, T. A. Verhulst, S. J. Main, B. J. Roberts, M. H. Potty, A. G. R. Pylawka, T. K. El-Amin III, S. F. Bone Joint Res General Orthopaedics OBJECTIVES: The purpose of this study was to evaluate in vivo biocompatibility of novel single-walled carbon nanotubes (SWCNT)/poly(lactic-co-glycolic acid) (PLAGA) composites for applications in bone and tissue regeneration. METHODS: A total of 60 Sprague-Dawley rats (125 g to 149 g) were implanted subcutaneously with SWCNT/PLAGA composites (10 mg SWCNT and 1gm PLAGA 12 mm diameter two-dimensional disks), and at two, four, eight and 12 weeks post-implantation were compared with control (Sham) and PLAGA (five rats per group/point in time). Rats were observed for signs of morbidity, overt toxicity, weight gain and food consumption, while haematology, urinalysis and histopathology were completed when the animals were killed. RESULTS: No mortality and clinical signs were observed. All groups showed consistent weight gain, and the rate of gain for each group was similar. All groups exhibited a similar pattern for food consumption. No difference in urinalysis, haematology, and absolute and relative organ weight was observed. A mild to moderate increase in the summary toxicity (sumtox) score was observed for PLAGA and SWCNT/PLAGA implanted animals, whereas the control animals did not show any response. Both PLAGA and SWCNT/PLAGA showed a significantly higher sumtox score compared with the control group at all time intervals. However, there was no significant difference between PLAGA and SWCNT/PLAGA groups. CONCLUSIONS: Our results demonstrate that SWCNT/PLAGA composites exhibited in vivo biocompatibility similar to the Food and Drug Administration approved biocompatible polymer, PLAGA, over a period of 12 weeks. These results showed potential of SWCNT/PLAGA composites for bone regeneration as the low percentage of SWCNT did not elicit a localised or general overt toxicity. Following the 12-week exposure, the material was considered to have an acceptable biocompatibility to warrant further long-term and more invasive in vivo studies. Cite this article: Bone Joint Res 2015;4:70–7 British Editorial Society of Bone and Joint Surgery 2015-05-01 /pmc/articles/PMC4438669/ /pubmed/25943595 http://dx.doi.org/10.1302/2046-3758.45.2000382 Text en ©2015 The British Editorial Society of Bone & Joint Surgery ©2015 The British Editorial Society of Bone & Joint Surgery. This is an open-access article distributed under the terms of the Creative Commons Attributions licence, which permits unrestricted use, distribution, and reproduction in any medium, but not for commercial gain, provided the original author and source are credited.
spellingShingle General Orthopaedics
Gupta, A.
Liberati, T. A.
Verhulst, S. J.
Main, B. J.
Roberts, M. H.
Potty, A. G. R.
Pylawka, T. K.
El-Amin III, S. F.
Biocompatibility of single-walled carbon nanotube composites for bone regeneration
title Biocompatibility of single-walled carbon nanotube composites for bone regeneration
title_full Biocompatibility of single-walled carbon nanotube composites for bone regeneration
title_fullStr Biocompatibility of single-walled carbon nanotube composites for bone regeneration
title_full_unstemmed Biocompatibility of single-walled carbon nanotube composites for bone regeneration
title_short Biocompatibility of single-walled carbon nanotube composites for bone regeneration
title_sort biocompatibility of single-walled carbon nanotube composites for bone regeneration
topic General Orthopaedics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438669/
https://www.ncbi.nlm.nih.gov/pubmed/25943595
http://dx.doi.org/10.1302/2046-3758.45.2000382
work_keys_str_mv AT guptaa biocompatibilityofsinglewalledcarbonnanotubecompositesforboneregeneration
AT liberatita biocompatibilityofsinglewalledcarbonnanotubecompositesforboneregeneration
AT verhulstsj biocompatibilityofsinglewalledcarbonnanotubecompositesforboneregeneration
AT mainbj biocompatibilityofsinglewalledcarbonnanotubecompositesforboneregeneration
AT robertsmh biocompatibilityofsinglewalledcarbonnanotubecompositesforboneregeneration
AT pottyagr biocompatibilityofsinglewalledcarbonnanotubecompositesforboneregeneration
AT pylawkatk biocompatibilityofsinglewalledcarbonnanotubecompositesforboneregeneration
AT elaminiiisf biocompatibilityofsinglewalledcarbonnanotubecompositesforboneregeneration